IDEAYA Biosciences

General Information


We are an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Our approach integrates extensive capabilities in identifying and validating translational biomarkers with small molecule drug discovery to select patient populations most likely to benefit from the targeted therapies we are developing. We are applying these capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality – which represents an emerging class of precision medicine targets.

Employees: 58
Founded: 2015
Contact Information
Address 7000 Shoreline Court, Suite 350, South San Francisco, CA 94080, US
Phone Number (650) 443-6209
Web Address
View Prospectus: IDEAYA Biosciences
Financial Information
Market Cap $194.8mil
Revenues $0 mil (last 12 months)
Net Income $-38.1 mil (last 12 months)
IPO Profile
Symbol IDYA
Exchange NASDAQ
Shares (millions): 5.0
Price range $10.00 - $10.00
Est. $ Volume $50.0 mil
Manager / Joint Managers J.P. Morgan/ Citigroup/ Jefferies
CO-Managers -
Expected To Trade: 5/23/2019
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change